TY - JOUR T1 - Feasibility Study of Mitigation and Suppression Intervention Strategies for Controlling COVID-19 Outbreaks in London and Wuhan JF - medRxiv DO - 10.1101/2020.04.01.20043794 SP - 2020.04.01.20043794 AU - Po Yang AU - Jun Qi AU - Shuhao Zhang AU - Xulong wang AU - Gaoshan Bi AU - Yun Yang AU - Bin Sheng Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/04/04/2020.04.01.20043794.abstract N2 - Recent outbreak of coronavirus disease 2019 (COVID-19) in China has lead a global pandemic around the world. For controlling COVID-19 outbreaks, most countries take two typical intervention strategies: suppression approach like immediately lock-downing cities at epicentre of and mitigation; or mitigation approach that slows down but not stopping epidemic of COVID-19 for reducing peak healthcare demand. Both strategies have their apparent merits and limitations; it becomes extremely hard to conduct one intervention strategy as the most feasible way to certain country. Targeting at this problem, this paper conducts a feasibility study by defining a mathematical model named SEMCR that access the effectiveness of mitigation, suppression and hybrid interventions for controlling COVID-19 outbreaks in London and Wuhan. The model first extends traditional SEIR (Susceptible-Exposed-Infectious-Recovered) model by considering one key fact: there is a direct link between Exposed and Recovered population. Then, it defines threshold and parameters to classify two stages of COVID control: active contain by isolation of cases and contacts, passive contain by suppression or mitigation. The model was fitted and evaluated with public dataset containing daily number of confirmed active cases including Wuhan, London, Hubei province and the UK during January, 2020 and March 2020. The simulated results show that 1) Suppression taken in Wuhan significantly reduces total exposed and infectious populations, but it has to be consistently maintained at least a period of 90 days (by the middle of April 2020) where its success relies on sufficient support from other parts of China. 2) In London, it is possible to take a hybrid intervention of suppression and mitigation for every 2 or 3 weeks over a longer period. While the total infectious populations will be doubled, the economic performance of London will be less affected due to limited mobility constraints. 3) Both in Wuhan and London cases, one important issue of fitting practical data is that there are a large portion (like 42.5% in Wuhan) of self-recovered population who are asymptomatic or mild symptomatic. These people might think they have been healthy at home because they did not go to hospital for COVID-19 tests. Early release of intervention intensity might increase a risk of the second breakout. One limitation of our model is that its prediction of infections and deaths depends on a parameter estimation of intervention intensity that presented by average-number contacts with susceptible individuals as infectious individuals in a certain region. We assume that each intervention has the same effect on the reproduction number in different regions over time. The practical effectiveness of implementing intervention intensity might be varied with respect to cultures or other issues of certain county.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work has been supported by the University of Sheffield.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe date in this manuscript are from public dataset, which has been referenced in the manuscript. ER -